parkinson’s disease
-
artificial-intelligence, Brain, digital health, dyskinesia, feasibility trial, levodopa, medication adherence, neuroscience, parkinson’s disease, UPDRS, wearing offAI Levodopa Timing Improved UPDRS 4.4 Points in 5 Parkinson Patients
A 2026 open-label feasibility trial involving 5 Parkinson’s disease patients found that…
-
apoptosis, Brain, Drosophila, immune genes, Neurodegenerative Diseases, neuroinflammation, neuroscience, oxidative stress, Parkin, parkinson’s disease, PINK1, rotenone, sex differences, sporadic Parkinsons disease, toxin modelParkinson’s Sex Differences: Male Flies Show Stronger Rotenone Stress
A 2026 Drosophila Parkinson’s model exposed male and female flies to 500…
-
ALS, Brain, cerebral palsy, digital biomarkers, dysarthria, HuBERT, motor speech disorder, Neurodegenerative Diseases, neuroscience, parkinson’s disease, phonological subspaces, speech AI, speech biomarkerDysarthria Speech Biomarker Tracked Severity Across 5 Languages
A 2026 medRxiv preprint found that a training-free speech biomarker tracked dysarthria…
-
Brain, connected speech, dysarthria, hypokinetic dysarthria, language planning, MoCA, Neurodegenerative Diseases, neuroscience, parkinson’s disease, sentence complexity, speech fluency, speech pausesParkinson’s Speech Pauses Track Sentence Complexity and MoCA Scores
A 2026 connected-speech study found that people with Parkinson’s disease produced more…
-
basal ganglia, Brain, deep brain stimulation, iTBS, MDS-UPDRS, Neurodegenerative Diseases, Neuromodulation, neuroscience, Neurostimulation, non invasive brain stimulation, parkinson’s disease, putamen, temporal interference stimulation, tTISTranscranial Temporal Interference Stimulation (tTIS) May Improve Parkinson’s Motor Symptoms
Deep brain stimulation works for Parkinson’s, but it requires implanted electrodes. A…
-
alpha-synuclein, ambroxol, biomarker, Brain, exenatide, exercise, GLP-1 agonist, Neurodegenerative Diseases, parkinson’s disease, Prevention, prodromal, Psychology, RBD, REM sleep behavior disorder, sleepParkinson’s Disease Prevention: Prodromal Symptoms, RBD, Early Intervention Trials
Parkinson’s disease has a years-to-decades prodromal stage where motor symptoms haven’t yet…
-
exenatide, GLP-1, lixisenatide, network meta-analysis, Neurodegenerative Diseases, neurology, neuroprotection, neuroscience, Ozempic, parkinson’s diseaseCan GLP-1 Drugs Slow Parkinson’s Disease? Evidence from 5 Trials
Research Highlights GLP-1 receptor agonists are diabetes drugs (Ozempic, Trulicity, Byetta) being…
-
bdnf, bdnf gene, dopamine, dopamine neurons, Drugs, gene therapy, genetics, motor behavior, motor symptoms, Neurodegenerative Diseases, parkinson’s disease, pramiprexole, transfectionBDNF Gene Transfection & Pramiprexole Combo Effectively Treat Parkinson’s Disease in Rat Models (2024 Study)
Parkinson’s disease (PD), a degenerative disorder that predominantly affects the motor system,…
